Stay updated on Pembrolizumab in MM Residual Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MM Residual Disease Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now includes links to related topics for Multiple Myeloma and MedlinePlus Genetics, expanding access to contextual information about the disease on the study record.
    Difference
    0.2%
    Check dated 2026-09-05T17:31:04.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A new page revision label Revision: v3.6.6 was added, indicating an update to the page metadata. The older revision label Revision: v3.6.5 and several topic tags (Multiple myeloma, related topics:, MedlinePlus Genetics) were removed, reflecting a cleanup of non-core content rather than changes to study details.
    Difference
    0.2%
    Check dated 2026-08-29T13:40:24.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now includes a 'Multiple myeloma' related topics section with a link to MedlinePlus Genetics, expanding cross-reference resources for readers.
    Difference
    0.2%
    Check dated 2026-08-15T03:57:15.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, representing a minor version bump. This update aligns with backend or template changes rather than a modification to the study content.
    Difference
    0.1%
    Check dated 2026-08-08T01:00:17.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page's disease label 'Multiple myeloma' and the related topics section, including the MedlinePlus Genetics link, were removed, reducing disease-specific context and cross-references.
    Difference
    0.2%
    Check dated 2026-08-01T01:13:28.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, indicating a backend/platform update. This change does not alter the study content, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-07-24T22:12:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MM Residual Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.